Checkpoint Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2014 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Checkpoint Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2014 to Q4 2024.
  • Checkpoint Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$28.9M, a 51.1% decline year-over-year.
  • Checkpoint Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$56.2M, a 8.47% decline year-over-year.
  • Checkpoint Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$56.2M, a 8.47% decline from 2023.
  • Checkpoint Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$51.8M, a 17.2% increase from 2022.
  • Checkpoint Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$62.6M, a 10.5% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$56.2M -$28.9M -$9.77M -51.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 -$46.5M -$9.73M -$4M -69.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$42.5M -$6.67M +$9.85M +59.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$52.3M -$10.9M -$471K -4.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$51.8M -$19.1M +$1.89M +9.01% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 -$53.7M -$5.72M +$4.89M +46.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$58.6M -$16.5M -$2.38M -16.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$56.3M -$10.5M +$6.37M +37.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$62.6M -$21M +$8.73M +29.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$71.4M -$10.6M +$653K +5.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$72M -$14.1M -$5M -54.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$67M -$16.8M -$10.3M -159% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$56.7M -$29.8M -$19.5M -191% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$37.1M -$11.3M -$6.34M -128% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$30.8M -$9.14M -$4.5M -96.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$26.3M -$6.51M -$3.22M -98.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$23.1M -$10.2M -$1.4M -15.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$21.7M -$4.93M +$276K +5.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$22M -$4.65M +$147K +3.07% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$22.1M -$3.28M +$2.61M +44.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$24.7M -$8.83M +$2.79M +24% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$27.5M -$5.21M +$4.14M +44.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$31.6M -$4.79M +$1.85M +27.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$33.5M -$5.89M +$2.88M +32.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$36.4M -$11.6M -$5.7M -96.3% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$30.7M -$9.34M -$3.42M -57.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$27.3M -$6.64M -$191K -2.96% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$27.1M -$8.77M -$4.38M -100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$22.7M -$5.92M +$2.41M +28.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$25.1M -$5.93M -$800K -15.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$24.3M -$6.45M -$1.04M -19.3% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$23.2M -$4.38M -$778K -21.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$22.5M -$8.32M -$272K -3.38% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$22.2M -$5.13M -$1.38M -36.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$20.8M -$5.41M -$4.93M -1038% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$15.9M -$3.61M -$1.99M -123% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$13.9M -$8.05M -$8.05M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-21
Q3 2015 -$5.84M -$3.75M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-21
Q2 2015 -$475K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-21
Q1 2015 -$1.62M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-21
Q4 2014 $0 Nov 10, 2014 Dec 31, 2014 10-K 2017-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.